These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4929477)

  • 21. Clinical experience in transplantation of the human heart: report of ten cases.
    Cooley DA; Nora JJ; Trentin JJ; Hallman GL; Bloodwell RD; Leachman RD
    Transplant Proc; 1969 Jun; 1(2):703-12. PubMed ID: 4939667
    [No Abstract]   [Full Text] [Related]  

  • 22. Sustained elevated concentrations of cardiac troponin T during acute allograft rejection after heart transplantation in children.
    Wåhlander H; Kjellström C; Holmgren D
    Transplantation; 2002 Oct; 74(8):1130-5. PubMed ID: 12438959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Current progress in heart and lung transplantation].
    Juszczyński M
    Kardiol Pol; 1983; 26(10):733-9. PubMed ID: 6420605
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical and pathological findings in human cardiac rejection.
    Ellis B; Madge G; Kolhatkar M; Still W
    Arch Pathol; 1971 Jul; 92(1):58-65. PubMed ID: 4933309
    [No Abstract]   [Full Text] [Related]  

  • 25. Diagnostic criteria of rejection in human heart transplantation.
    Dyrda I
    Laval Med; 1970 Feb; 41(2):262-5. PubMed ID: 4929503
    [No Abstract]   [Full Text] [Related]  

  • 26. Additive value of immunologic monitoring to histologic grading of heart allograft biopsy specimens: implications for therapy.
    Fisher PE; Suciu-Foca N; Ho E; Michler RE; Rose EA; Mancini D
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1156-61. PubMed ID: 8719463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Advances in the pathology of human cardiac transplantation].
    Zhao H; You L; Wei L
    Zhonghua Yi Xue Za Zhi; 1995 Jul; 75(7):440-3. PubMed ID: 7553164
    [No Abstract]   [Full Text] [Related]  

  • 28. [A critical review of the role of endomyocardial biopsy in heart transplantation].
    Vázquez de Prada JA
    Rev Esp Cardiol; 1995; 48 Suppl 7():86-91. PubMed ID: 8775822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelin plasma levels in acute graft rejection after heart transplantation.
    Dengler TJ; Zimmermann R; Tiefenbacher CP; Braun K; Sack FU; Kübler W
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1057-64. PubMed ID: 8719451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Rejection phenomenon in heart transplantation. Histopathological and immunohistochemical findings].
    Fujimoto T; Matsuyama T
    Arerugi; 1969 Oct; 18(10):801-8. PubMed ID: 4900846
    [No Abstract]   [Full Text] [Related]  

  • 31. [Immunomorphology and pathology of the allotransplanted heart (without immunodepressive effect)].
    Rapoport IaL; Fal'kovskiĭ GE; Galankina IE
    Arkh Patol; 1971; 33(4):43-9. PubMed ID: 4945787
    [No Abstract]   [Full Text] [Related]  

  • 32. Hormonal therapy of the brain-dead organ donor: experimental and clinical studies.
    Novitzky D; Cooper DK; Rosendale JD; Kauffman HM
    Transplantation; 2006 Dec; 82(11):1396-401. PubMed ID: 17164704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experience with cardiac transplantation in fourteen patients.
    Stinson EB; Schroeder JS; Harrison DC; Dong E; Popp RL; Shumway NE
    Laval Med; 1970 Feb; 41(2):125-9. PubMed ID: 4929478
    [No Abstract]   [Full Text] [Related]  

  • 34. Timing of the first endomyocardial biopsy in heart transplantation after induction immunosuppressive therapy--experience from Canadian Heart Transplant Centre.
    Málek F; Kaan A; Straatman L; Cheung A; Gnaszewski A
    Cas Lek Cesk; 2005; 144(8):507-9; discussion 509. PubMed ID: 16173602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heart-reactive antibody: a monitor of cardiac rejection.
    Ellis RJ; Zabriskie JB
    Transplant Proc; 1971 Mar; 3(1):905-7. PubMed ID: 4937990
    [No Abstract]   [Full Text] [Related]  

  • 36. Human heterotopic cardiac transplantation: current status.
    Wolpowitz A; Losman JG; Curcio CA; Barnard MS; Sánchez HE; Barnard CN
    S Afr J Surg; 1978 Jun; 16(2):99-102. PubMed ID: 362566
    [No Abstract]   [Full Text] [Related]  

  • 37. Major histocompatibility complex-expressing human cardiac myocytes are not the direct target of host cardiac-infiltrating cells: evidence for a prominent role of the indirect pathway in human cardiac allograft rejection.
    Ansari AA; Kanter K; Wang YC; Mayne A; Sell KW; Herskowitz A
    Transplant Proc; 1993 Feb; 25(1 Pt 1):89-93. PubMed ID: 8438502
    [No Abstract]   [Full Text] [Related]  

  • 38. Neuroendocrine profiling of humans receiving cardiac allografts.
    Ogawa T; Veinot JP; Davies RA; Haddad H; Smith SJ; Masters RG; Hendry PJ; Starling R; de Bold MK; Ponce A; Ma KK; Williams K; de Bold AJ
    J Heart Lung Transplant; 2005 Aug; 24(8):1046-54. PubMed ID: 16102440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical experience in cardiac transplantation.
    Lower RR; Kemp VE; Graham WH
    Laval Med; 1970 Feb; 41(2):134-8. PubMed ID: 4929480
    [No Abstract]   [Full Text] [Related]  

  • 40. Synergistic effects of malononitrilamides (FK778, FK779) with tacrolimus (FK506) in prevention of acute heart and kidney allograft rejection and reversal of ongoing heart allograft rejection in the rat.
    Bilolo KK; Ouyang J; Wang X; Zhu S; Jiang W; Qi S; Xu D; Hebert MJ; Bekersky I; Fitzsimmons WE; Chen H
    Transplantation; 2003 Jun; 75(11):1881-7. PubMed ID: 12811249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.